These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25201577)

  • 1. Association between a functional polymorphism rs712 within let-7-binding site and risk of papillary thyroid cancer.
    Jin H; Liang Y; Wang X; Zhu J; Sun R; Chen P; Nie X; Gao L; Zhang L
    Med Oncol; 2014 Oct; 31(10):221. PubMed ID: 25201577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A let-7 binding site polymorphism rs712 in the KRAS 3' UTR is associated with an increased risk of gastric cancer.
    Li ZH; Pan XM; Han BW; Guo XM; Zhang Z; Jia J; Gao LB
    Tumour Biol; 2013 Oct; 34(5):3159-63. PubMed ID: 23729275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A let-7 KRAS rs712 polymorphism increases colorectal cancer risk.
    Pan XM; Sun RF; Li ZH; Guo XM; Zhang Z; Qin HJ; Xu GH; Gao LB
    Tumour Biol; 2014 Jan; 35(1):831-5. PubMed ID: 23975373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer.
    Huang X; Yang Y; Guo Y; Cao ZL; Cui ZW; Hu TC; Gao LB
    Genet Mol Res; 2015 Dec; 14(4):16913-20. PubMed ID: 26681038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association between let-7 binding site polymorphism rs712 and risk of nasopharyngeal carcinoma.
    Pan XM; Jia J; Guo XM; Li ZH; Zhang Z; Qin HJ; Xu GH; Gao LB
    Fam Cancer; 2014 Mar; 13(1):93-7. PubMed ID: 23996697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single nuclear polymorphism in let-7g binding site affects the doubling time of thyroid nodule by regulating KRAS-induced cell proliferation.
    Liu A; Zhang W; Zhao T; Xiao M; Mei Q; Zhu H
    J Cell Physiol; 2019 Dec; 234(12):23437-23447. PubMed ID: 31152438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association analysis between the interaction of RAS family genes mutations and papillary thyroid carcinoma in the Han Chinese population.
    Jin M; Li Z; Sun Y; Zhang M; Chen X; Zhao H; Yu Q
    Int J Med Sci; 2021; 18(2):441-447. PubMed ID: 33390813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Functional Polymorphism in the Promoter of MiR-143/145 Is Associated With the Risk of Cervical Squamous Cell Carcinoma in Chinese Women: A Case-Control Study.
    Liang Y; Sun R; Li L; Yuan F; Liang W; Wang L; Nie X; Chen P; Zhang L; Gao L
    Medicine (Baltimore); 2015 Aug; 94(31):e1289. PubMed ID: 26252302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive sequence variation in the 3' untranslated region of the KRAS gene in lung and ovarian cancer cases.
    Kim M; Chen X; Chin LJ; Paranjape T; Speed WC; Kidd KK; Zhao H; Weidhaas JB; Slack FJ
    Cell Cycle; 2014; 13(6):1030-40. PubMed ID: 24552817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Genetic Polymorphisms in the Promoter Regions of Let-7 and Risk of Papillary Thyroid Carcinoma: A Case-Control Study.
    Wang Y; Wei T; Xiong J; Chen P; Wang X; Zhang L; Gao L; Zhu J
    Medicine (Baltimore); 2015 Oct; 94(43):e1879. PubMed ID: 26512603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A subset of papillary thyroid carcinomas contain KRAS mutant subpopulations at levels above normal thyroid.
    Myers MB; McKim KL; Parsons BL
    Mol Carcinog; 2014 Feb; 53(2):159-67. PubMed ID: 22930660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An let-7 KRAS rs712 polymorphism increases hepatocellular carcinoma risk.
    Xiong D; Song YP; Xiong W; Liang YD
    Genet Mol Res; 2015 Oct; 14(4):14050-5. PubMed ID: 26535719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between microRNA polymorphisms and papillary thyroid cancer susceptibility.
    Dong G; Zhang R; Xu J; Guo Y
    Int J Clin Exp Pathol; 2015; 8(10):13450-7. PubMed ID: 26722556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of rs712 polymorphism in Kras gene 3'-luntranslated region and cancer risk: a meta-analysis.
    Zhao WH; Qu XF; Xing ZG; Zhao LQ; Qin L; Lv C
    J BUON; 2015; 20(1):309-16. PubMed ID: 25778332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of KRAS mutation and polymorphism on the risk and prognosis of oral squamous cell carcinoma.
    Wang WY; Chien YC; Wong YK; Lin YL; Lin JC
    Head Neck; 2012 May; 34(5):663-6. PubMed ID: 21688344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma.
    Zou M; Baitei EY; Alzahrani AS; BinHumaid FS; Alkhafaji D; Al-Rijjal RA; Meyer BF; Shi Y
    Thyroid; 2014 Aug; 24(8):1256-66. PubMed ID: 24798740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between the
    Ning L; Rao W; Yu Y; Liu X; Pan Y; Ma Y; Liu R; Zhang S; Sun H; Yu Q
    J Cancer; 2016; 7(15):2420-2426. PubMed ID: 27994680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers.
    Christensen BC; Moyer BJ; Avissar M; Ouellet LG; Plaza SL; McClean MD; Marsit CJ; Kelsey KT
    Carcinogenesis; 2009 Jun; 30(6):1003-7. PubMed ID: 19380522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of the miR-149 Rs2292832 polymorphism with papillary thyroid cancer risk and clinicopathologic characteristics in a Chinese population.
    Wei WJ; Lu ZW; Li DS; Wang Y; Zhu YX; Wang ZY; Wu Y; Wang YL; Ji QH
    Int J Mol Sci; 2014 Nov; 15(11):20968-81. PubMed ID: 25405731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant association between Let-7-KRAS rs712 G > T polymorphism and cancer risk in the Chinese population: a meta-analysis.
    Du XY; Hu YY; Xie C; Deng CY; Liu CY; Luo ZG; Niu YM; Shen M
    Oncotarget; 2017 Feb; 8(8):13863-13871. PubMed ID: 28099923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.